["{\n\"step_by_step_thinking\": \"Since the question is asking about the cells with greatest affinity to bisphosphonates, we should focus on the documents that discuss the effects of bisphosphonates on different cell types. The first document discusses the modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants. It highlights the differences among the bisphosphonates tested and mentions that Me2APD, at low concentrations, can enhance PTH-stimulated osteoclastic resorption. This suggests that bisphosphonates may have a specific effect on osteoclasts.\n\nThe second document discusses the potential use of bisphosphonates in the treatment of renal osteodystrophy and mentions their efficacy in decreasing bone turnover related to increased parathyroid hormone effects. This implies that bisphosphonates may be effective against osteoclasts, which are responsible for excessive bone resorption.\n\nThe third document discusses the use of bisphosphonates in the treatment of osteoporosis and highlights their ability to decrease bone resorption and increase spinal bone density. This suggests that bisphosphonates may have a positive effect on osteoclasts.\n\nGiven these findings, it appears that osteoclasts are the cells with greatest affinity to bisphosphonates.\",\n\"answer_choice\": C"]